ADVANCE infectious diseases pharmacy and LEAD antimicrobial stewardship in order
to OPTIMIZE the care of patients

  • Home
  • About
  • News
  • SIDP supports legislation targeting antimicrobial resistance

SIDP supports legislation targeting antimicrobial resistance

16 Aug 2019 10:07 AM | Anonymous
SIDP is supportive of S.2172, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2019. This bipartisan legislation seeks to increase Medicare reimbursement for specified antibiotics through removal of qualified antibiotics from the Diagnosis-Related Group (DRG). In order to participate, hospitals must have an antibiotic stewardship program in place that is consistent with the CDC Core Elements of Hospital Antibiotic Stewardship Programs. The legislation would also require participating hospitals to report antibiotic use and resistance through the CDC National Healthcare Safety Network Antimicrobial Use and Resistance Module.  A similar bill was introduced in the House of Representatives under H.R. 4100 on July 30, 2019.  SIDP has signed on to a letter of support with other infectious diseases organizations for both bills.

The Strategies to Address Antimicrobial Resistance (STAAR) Act was reintroduced by Senator Sherrod Brown (D-OH). Additional information on the bill will posted when it is available at www.congress.gov . Similar to the DISARM Act, SIDP has signed on to a letter of support with other infectious diseases organizations for both bills.

 


Society of Infectious Diseases Pharmacists •  121 W. State Street, Geneva, IL 60134
(630) 938-4732sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software